Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Infliximab Tx Effects Dramatic in Psoriasis and Psoriatic Arthritis
Chicago - Results of two multicenter, double-blind, placebo-controlled trials support the conclusion that the TNF-a chimeric monoclonal antibody infliximab (Remicade) is a highly effective and generally well-tolerated treatment for psoriasis and psoriatic arthritis, Alan D. Menter, M.D., said.
Related Videos
Related Content
